Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Shigellosis”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Early research (Phase 1)Study completedNCT02797236
What this trial is testing

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

Who this might be right for
ShigellosisBacillary Dysentery
Institut Pasteur 64
Testing effectiveness (Phase 2)Study completedNCT04602975
What this trial is testing

Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a

Who this might be right for
Healthy
Institut Pasteur 248
Early research (Phase 1)Study completedNCT01336699
What this trial is testing

Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Who this might be right for
Shigella Infection
National Institute of Allergy and Infectious Diseases (NIAID) 89
Testing effectiveness (Phase 2)Study completedNCT02676895
What this trial is testing

The Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Who this might be right for
Shigella Sonnei Infection
GlaxoSmithKline 74
Testing effectiveness (Phase 2)Study completedNCT04865497
What this trial is testing

Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old

Who this might be right for
DysenteryDysentery, Bacillary
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,050
Early research (Phase 1)Study completedNCT01509846
What this trial is testing

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Who this might be right for
Shigellosis
PATH 82
Early research (Phase 1)Looking for participantsNCT07205926
What this trial is testing

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

Who this might be right for
ShigellaDiarrhea
Inventprise Inc. 60
Testing effectiveness (Phase 2)Study completedNCT03527173
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 71
Early research (Phase 1)Study completedNCT02034500
What this trial is testing

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Who this might be right for
Shigellosis
GSK Vaccines Institute For Global Health S.r.l. 52
Early research (Phase 1)Study completedNCT01369927
What this trial is testing

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

Who this might be right for
ImmunogenicityShigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 60
Not applicableStudy completedNCT02516683
What this trial is testing

The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study

Who this might be right for
Shigella Sonnei Infection
Yonsei University 229
Not applicableStudy completedNCT01813071
What this trial is testing

Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and Children

Who this might be right for
Diarrhea
PATH 103
Large-scale testing (Phase 3)UnknownNCT05156528
What this trial is testing

Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

Who this might be right for
DysenteryShigellosis
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 21,000
Testing effectiveness (Phase 2)Study completedNCT00485134
What this trial is testing

Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection

Who this might be right for
Shigellosis
U.S. Army Medical Research and Development Command 113
Testing effectiveness (Phase 2)Ended earlyNCT00866242
What this trial is testing

Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

Who this might be right for
Shigella
University of Maryland, Baltimore 20
Testing effectiveness (Phase 2)Looking for participantsNCT07433426
What this trial is testing

The Impact of Shigellosis and Recommended Treatment in Children

Who this might be right for
Diarrhea InfectiousShigellaGrowth & Development
Johns Hopkins Bloomberg School of Public Health 700
Early research (Phase 1)Study completedNCT04634513
What this trial is testing

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Who this might be right for
Shigella InfectionEnterotoxigenic Escherichia Coli Infection
University of Maryland, Baltimore 53
Early research (Phase 1)Study completedNCT01531530
What this trial is testing

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Who this might be right for
Shigella
University of Maryland, Baltimore 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06615375
What this trial is testing

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

Who this might be right for
Shigellosis
LimmaTech Biologics AG 120
Testing effectiveness (Phase 2)Study completedNCT04056117
What this trial is testing

Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants

Who this might be right for
Shigellosis
LimmaTech Biologics AG 596
Load More Results